← Open Payments lookup

JACQUELINE WIAND: Open Payments

NPI 1881023190 · MANSFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$516 in 24 payments from 8 companies in 2025. Trend: 2023 $239 · 2024 $335 · 2025 $516

Food & beverage: $516
CompanyPaymentsAmount
ABBVIE INC.8$187
Vanda Pharmaceuticals Inc.4$97
Alkermes, Inc.3$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$62
Otsuka America Pharmaceutical, Inc.2$31
Teva Pharmaceuticals USA, Inc.1$23
Neurocrine BioSciences, Inc.1$21
Novo Nordisk Inc1$14

Products named: VRAYLAR, FANAPT, LYBALVI, CAPLYTA, ABILIFY MAINTENA, UZEDY, INGREZZA, Ozempic.

Industry payments across PA — which companies pay providers there.